The Future of Digital Biomarkers: With Manjit Mooker

The Future of Digital Biomarkers: With Manjit Mooker

In this episode of the Medtech Ventures podcast, host Craig Townsend speaks with serial entrepreneur Manjit Mooker [https://www.linkedin.com/in/manjitmooker/?originalSubdomain=uk]about his journey in telemedicine and digital biomarkers. Manjit shares insights on the challenges of launching a telemedicine business, the importance of problem-solving in start-up, and his current focus on digital biomarkers. He discusses the funding landscape, the pitfalls of entrepreneurship, and offers valuable advice for aspiring founders. Listen or download our podcast on the first Thursday of each month and follow ⁠⁠⁠⁠⁠Craig⁠⁠⁠⁠⁠ [https://www.linkedin.com/in/craig-c-townsend/] on LinkedIn.

CeraThrive: Biohacking with Red Light Therapy

In this episode of the MedTech Ventures podcast, Craig Townsend interviews Sarah Turner [https://www.linkedin.com/in/rebelscientist?originalSubdomain=uk], CEO and co-founder of CeraThrive [https://www.cerathrive.com/?utm_term=cerathrive&utm_campaign=Search+-+US+Focus+-+Maximize+Sales&utm_source=adwords&utm_medium=ppc&hsa_acc=8048182888&hsa_cam=22395262471&hsa_grp=180355173114&hsa_ad=742941823387&hsa_src=g&hsa_tgt=kwd-2203995786946&hsa_kw=cerathrive&hsa_mt=b&hsa_net=adwords&hsa_ver=3&gad_source=1&gad_campaignid=22395262471&gbraid=0AAAAAqqdQDptHLNTNkqIKHflvbzfh1sHW&gclid=CjwKCAjw6NrBBhB6EiwAvnT_rhGAhn_cRDap1_8igs7QwgzgrN8Vo4NnevjMMeV97wYxRsSFn4gFxBoCIjYQAvD_BwE], about the innovative applications of red light therapy in wellness and medical technology. Sarah presents the Cera system, a dual device targeting gut and brain health utilising red light therapy. The conversation delves into the science behind red light therapy, regulatory challenges, market adoption, and the future of the industry, including the integration of AI and its role in anti-aging and longevity. Listen or download our podcast bi-weekly on Thursdays. Follow ⁠⁠⁠⁠Craig⁠⁠⁠⁠ [https://www.linkedin.com/in/craig-c-townsend/] on LinkedIn.

VentriJect: Prioritising VO2 Max Testing

In this episode of the Medtech Ventures podcast, Craig Townsend interviews Kasper Sørensen [https://www.linkedin.com/in/soerensen-kasper/], CTO and co-founder of VentriJect [https://ventriject.com/], about the Seismofit, technology for estimating VO2 max. They discuss Kasper's journey from academia to entrepreneurship, the challenges of developing a medical device, navigating regulatory landscapes, and the importance of VO2 max as a vital sign monitor. The conversation also explores the future of cardiorespiratory health and AI. Kasper shares valuable insights for aspiring entrepreneurs, emphasizing the importance of pursuing good ideas. Listen or download our podcast bi-weekly on Thursdays. Follow ⁠⁠⁠Craig⁠⁠⁠ [https://www.linkedin.com/in/craig-c-townsend/] on LinkedIn.

Eyes on Innovation: Ophthalmic Screening with Neocam & DigiVis

In this episode of the MedTech Ventures podcast, Dr. Louise Allen [https://www.linkedin.com/in/louise-allen-383466142/], consultant ophthalmologist, shares her journey in paediatric ophthalmology and entrepreneurship. We discuss the importance of early detection in children's eye health, the challenges of implementing new technologies in the NHS, and the significance of patient feedback in developing medical devices. Dr. Allen also highlights her experiences with funding and commercialisation strategies for her innovations, emphasising the need for collaboration and seeking advice early in the entrepreneurial journey. Listen or download our podcast bi-weekly on Thursdays. Follow ⁠⁠⁠⁠Craig⁠⁠⁠⁠ [https://www.linkedin.com/in/craig-c-townsend/] on LinkedIn.

DLOC Biosystems: Innovation in Drug Testing

In this episode of the Medtech Ventures podcast, Craig [https://www.linkedin.com/in/craig-c-townsend/]interviews Wadah Malaeb [https://www.linkedin.com/in/waddah-malaeb/], CEO and founder of DLOC Biosystems [https://www.dlocbiosystems.com/], about the innovative work being done in organ-on-a-chip technology. Wadah shares his journey from mechanical engineering to biotech founder, the unique approach of DLOC in creating models that mimic human physiology, and the challenges faced by startups in the biotech space. He discusses the importance of funding, collaboration, and the future of drug testing and precision medicine, while also addressing ethical considerations in patient data. Wadah emphasizes the need for flexibility and perseverance in entrepreneurship, providing valuable insights for aspiring founders. Listen or download our podcast bi-weekly on Thursdays. Follow ⁠⁠Craig⁠⁠ [https://www.linkedin.com/in/craig-c-townsend/] on LinkedIn.